MDM2 and glioblastoma: In U87MG glioblastoma, PTEN protected p53 through inhibition of phosphophatidylinositol 3-kinase (PI3K)/Akt signaling (activation known to promote Mdm2 translocation into the nucleus), resulting in Mdm2 restriction to the cytoplasm, where it is degraded.